Trial Profile
A Prospective, Post Marketing Observational Study to Evaluate the Safety of Pletaal SR Capsule
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Feb 2019
Price :
$35
*
At a glance
- Drugs Cilostazol (Primary)
- Indications Cerebral infarction; Embolism and thrombosis
- Focus Adverse reactions
- Acronyms PLTSRPMOS
- Sponsors Korea Otsuka Pharmaceutical
- 14 Sep 2018 Status changed from not yet recruiting to completed.
- 11 Feb 2013 New trial record